Metlife is a property & casualty insurance company located in New York, United States, which is part of the Financial Services sector, and is traded under the ticker MET on the NYSE exchange.
Metlife stock last closed at $67.97, down 1.19% from the previous day, and has decreased 12.52% in one year. It has underperformed other stocks in the Insurance - Life industry by 0.12 percentage points. Metlife stock is currently +4.23% from its 52-week low of $65.21, and -20.04% from its 52-week high of $85.00.
As of Mar 13, 2026, there are 652.05M shares of MET outstanding. The market value of MET is $44.32B. In the past 24 hours, 3.21M MET shares were traded.
You will need an online brokerage account to access the NYSE market and buy MET shares.
Based on our experience, eToro is the best stock brokerage. eToro gives you:
Get $10 towards your stock purchase by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've picked your brokerage, it's time to fill out some personal details so you can invest in MET stock today.
Now that you've opened your account on one of the best stock apps, you can securely and quickly fund your account:
Watch the walkthrough below for more details depositing funds into your investment account.
Once you have identified the best place to buy Metlife stock, it's very important to research their stock prior to investing, so you actually wrap your head around the risk as well as the opportunity.
WallStreetZen was created to help everyday investors perform better fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on MET's stock page.
You can use a variety of different financial metrics, analyses, models, and charts to gauge MET's fair value.
Using relative valuations methods:
You can access more valuation research on MET's stock here.
Out of 12 Wall Street analysts who give recommendations on MET, the consensus analyst rating on Metlife is a Strong Buy
Please note that analyst ratings are not stock recommendations, nor are they financial advice.
Elyse Greenspan, a top 4% analyst from Wells Fargo maintains MET with a strong buy rating and raises their MET price target from $94.00 to $97.00, on Jan 13, 2026.
Wells Fargo's Elyse Greenspan raised their price target on Metlife (NYSE: MET) by 3.2% from $94 to $97 on 2026/01/13. The analyst maintained their Strong Buy rating on the stock.
Greenspan's price target hike on MetLife was delivered in a quarterly preview of names in their Insurance portfolio.
According to the analyst, investors should focus on different metrics by segment, specifically:
Yaron Kinar, a top 17% analyst from Mizuho initiates coverage on MET with a buy rating and announces their MET price target of $101.00, on Dec 16, 2025.
Ryan Krueger, a top 29% analyst from Keefe, Bruyette & Woods maintains MET with a buy rating and lowers their MET price target from $92.00 to $90.00, on Nov 11, 2025.
Joshua Shanker, a top 15% analyst from Bank of America maintains MET with a strong buy rating and lowers their MET price target from $104.00 to $100.00, on Nov 6, 2025.
Alex Scott, a top 17% analyst from Barclays maintains MET with a strong buy rating and raises their MET price target from $93.00 to $98.00, on Oct 8, 2025.
You can dive deeper into what analysts are forecasting on the Metlife stock forecast page.
Last year, MET earnings were $3.17B. Over the past 5 year, MET's earnings have increased by -3.69% per year. This was slower than the Insurance - Life industry average of -1.29%.
Last year, MET revenue was $77.08B. In the past 5 year, MET's revenue has grown by 2.59% per year. This was faster than the Insurance - Life industry average of -4.36%.
Dive into MET's earnings and revenue performance here.
Over the past 12 months, executives and large shareholders at MET have sold more shares than they have bought.
Carla A. Harris, Director of MET, was the latest MET insider to buy. They bought $3,035.80 worth of MET stock on Mar 10, 2026.
Learn more about who owns MET shares here.
Metlife pays a dividend of 3.34%, compared to the Insurance - Life industry's average dividend yield of 2.4%. If you owned $1,000 worth of MET stock, you would have received $33.42 in the past 12 months.
Metlife dividend payments have consistently grown over the past decade and have remained stable.
Dig into more data about Metlife dividend yield and history here.
One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
You have two main options:
Click the Open Trade button and your broker will execute the order.
If you need additional assistance investing in stocks on eToro, watch the how to video below:
Now that you own some shares in MET, you'll want to keep up with your stock purchase.
Start a watchlist to get notified of important updates regarding your MET stock.
To summarize, here are the 6 steps for buying Metlife stock:
If you require a brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you want to get notifications regarding your new investment in Metlife, create a watchlist on WallStreetZen today.